Supply of Essential Injectable Pharmaceuticals and Infusions for Mata Gujri Hospital

Work Description - NA

This tender, bid number GEM/2026/B/7888761, issued by the Municipal Corporation of Delhi (MCD) for the Mata Gujri Hospital in Tilak Nagar, New Delhi, seeks the supply of a comprehensive range of essential injectable pharmaceuticals and infusions. The contract is open for bidding from August 13, 2026, 9:52 PM until August 29, 2026, 9:00 AM. The scope of supply encompasses a substantial total quantity of 49,240 units, covering critical medications such as Glycopyrrolate, Neostigmine, Phenobarbitone, Phenytoin Sodium, Potassium Chloride, Diltiazem, Diazepam, Levetiracetam, Lorazepam, Lidocaine formulations, Multivitamin Infusion, Nitroglycerine, Prochlorperazine, Triamcinolone, Mitomycin, Atropine, Clonidine, Ketamine, Loxicard (2% and 4%), Lignocaine (2%), Myopyrolate, Pilocarpine, Hyaluronidase, and Tetanus Toxoid. Additionally, the tender includes supplies of Infusion Normal Saline 3 Percent, Etophylline plus Theophylline, Aspart Insulin, Iron Sucrose, Ethamsylate, Human Actrapid - Regular Insulin, Heparin, Ondansetron, Ranitidine, and Dexamethasone. This procurement is vital for the operational needs of the MCD's healthcare facilities in Delhi.